含硫类的广泛抗病毒药物改善了流感病毒疫苗开发
David W Buchholz1, Armando Pacheco1,2, Sreetama Pal3
1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Nature communications
|January 6, 2026
概括
新的抗病毒化合物 (XM系列) 通过改变病毒膜,广泛抑制包裹病毒. 使用XM-01的全新无活化流感病毒 (IIV) 疫苗在小鼠中显示出增强的免疫反应和保护.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 药用化学 医学化学
背景情况:
- 包裹病毒构成重大流行病威胁.
- 广泛的抗病毒药物对公共卫生至关重要.
- 目前的无活化疫苗有其局限性.
研究的目的:
- 识别和表征新的广泛抗病毒化合物.
- 研究这些化合物的作用机制.
- 开发和评估一种新的非活化流感病毒 (IIV) 疫苗配方.
主要方法:
- 小分子含硫化合物的选 (XM系列).
- 病毒膜特性 (脂质组成,顺序,相变) 的多学科分析.
- 基于XM-01的整体无活化流感病毒 (IIV) 疫苗的开发.
- 在小鼠模型中进行免疫和挑战研究.
主要成果:
- 通过破坏病毒膜完整性,XM化合物在很大程度上抑制了包裹病毒.
- 与传统的无活化疫苗相比,XM-01-IIV引发了优异的中和抗体反应.
- 接种XM-01-IIV疫苗可以显著保护小鼠免受流感挑战.
结论:
- XM系列化合物代表了一个有前途的新类宽频抗病毒药物.
- XM-01-IIV是一种针对包裹病毒的强有力的疫苗候选者.
- 这种方法可以提高失活疫苗对抗流行病威胁的有效性.
相关概念视频
Subviral Agents
502
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
502
Leaky Scanning
5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K


